ASSOCIATION OF LIPOPROTEIN(A) WITH PUBERTY IN IDDM

被引:40
作者
COUPER, JJ
BATES, DJ
COCCIOLONE, R
MAGAREY, AM
BOULTON, TJC
PENFOLD, JL
RYALL, RG
机构
[1] UNIV ADELAIDE,ADELAIDE CHILDRENS HOSP,DEPT ENDOCRINOL & DIABET,ADELAIDE,SA 5006,AUSTRALIA
[2] UNIV ADELAIDE,ADELAIDE CHILDRENS HOSP,DEPT CHEM PATHOL,ADELAIDE,SA 5006,AUSTRALIA
[3] UNIV ADELAIDE,ADELAIDE CHILDRENS HOSP,DEPT NUTR & DIETET,ADELAIDE,SA 5006,AUSTRALIA
[4] UNIV NEWCASTLE,DEPT PEDIAT,NEWCASTLE,NSW 2308,AUSTRALIA
关键词
D O I
10.2337/diacare.16.6.869
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- To determine serum lipoprotein(a) in a large sample of IDDM and control children and to examine a possible association with puberty. RESEARCH DESIGN AND METHODS- Serum lipoprotein(a), apoB-100, and apoA-I were measured under identical conditions in 170 Caucasian children with IDDM aged 12.3 +/- 3.59 yr and 233 Caucasian control children aged 13.6 +/- 1.12 yr. Patients with persistent microalbuminuria were excluded. Lipoprotein(a), apoB-100, and apoA-I were measured by nephelometry using a specific monoclonal antibody. Pubertal assessment was performed using Tanner staging and testicular volume measurement. RESULTS - Lipoprotein(a) was higher in the IDDM than control group (geometric mean 237 mg/L, 25-75th percentile 134-465 vs. 172 [99-316] mg/L, P = 0.0008). When analyzed according to pubertal stage, only pubertal and postpubertal patients had higher levels than control subjects (265 [148-560] vs. 174 [101-320] mg/L, P = 0. 000 1), with prepubertal patients showing no difference. Pubertal and postpubertal patients showed both higher lipoprotein(a) (P = 0.01) levels and higher albumin excretion rates (P = 0.02) than prepubertal patients, correcting for the other variable. Lipoprotein(a) was not related to HbA1c, albumin excretion rate, duration, age, sex, mean arterial pressure, or a family history of premature coronary artery disease in the IDDM group. Lipoprotein(a) was not higher in patients with overnight albumin excretion rate above the 95th percentile but below the microalbuminuric range. ApoB-100 did not differ between IDDM and control children. ApoA-I was significantly lower in the IDDM group (1.04 [0.94-1.17] vs. 1.21 [1.10-1.31] g/L; P < 0.0001). CONCLUSIONS- Pubertal and postpubertal IDDM patients have higher serum lipoprotein(a) than Caucasian control subjects. Our findings suggest a rise in lipoprotein(a) may occur during puberty in IDDM. Longitudinal studies are required to clarify the relationship between lipoprotein(a), albumin excretion rate, and puberty.
引用
收藏
页码:869 / 873
页数:5
相关论文
共 35 条
  • [1] ALBERS JJ, 1990, CLIN CHEM, V36, P2019
  • [2] IMPAIRED INSULIN ACTION IN PUBERTY - A CONTRIBUTING FACTOR TO POOR GLYCEMIC CONTROL IN ADOLESCENTS WITH DIABETES
    AMIEL, SA
    SHERWIN, RS
    SIMONSON, DC
    LAURITANO, AA
    TAMBORLANE, WV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) : 215 - 219
  • [3] BERG K, 1963, ACTA PATHOL MIC SC, V59, P369
  • [4] PROTEINURIA - VALUE AS PREDICTOR OF CARDIOVASCULAR MORTALITY IN INSULIN-DEPENDENT DIABETES-MELLITUS
    BORCHJOHNSEN, K
    KREINER, S
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1987, 294 (6588): : 1651 - 1654
  • [5] INCREASED SERUM LEVELS OF LIPOPROTEIN(A) IN DIABETES-MELLITUS AND THEIR REDUCTION WITH GLYCEMIC CONTROL
    BRUCKERT, E
    DAVIDOFF, P
    GRIMALDI, A
    TRUFFERT, J
    GIRAL, P
    DOUMITH, R
    THERVET, F
    DEGENNES, JL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (01): : 35 - 36
  • [6] THE DETERMINATION OF LIPOPROTEIN LP(A) BY RATE AND ENDPOINT NEPHELOMETRY
    CAZZOLATO, G
    PRAKASCH, G
    GREEN, S
    KOSTNER, GM
    [J]. CLINICA CHIMICA ACTA, 1983, 135 (02) : 203 - 208
  • [7] CHASE HP, 1991, CLIN CHEM, V37, P2048
  • [8] DURRINGTON PN, 1988, LANCET, V1, P1070
  • [9] INCREASED OVERNIGHT GROWTH-HORMONE CONCENTRATIONS IN DIABETIC COMPARED WITH NORMAL ADOLESCENTS
    EDGE, JA
    DUNGER, DB
    MATTHEWS, DR
    GILBERT, JP
    SMITH, CP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (05) : 1356 - 1362
  • [10] GAUBATZ JW, 1990, J LIPID RES, V31, P603